206 related articles for article (PubMed ID: 25012880)
1. The quality of general movements after treatment with low-dose dexamethasone in preterm infants at risk of bronchopulmonary dysplasia.
Hitzert MM; Roescher AM; Bos AF
Neonatology; 2014; 106(3):222-8. PubMed ID: 25012880
[TBL] [Abstract][Full Text] [Related]
2. Hydrocortisone vs. dexamethasone treatment for bronchopulmonary dysplasia and their effects on general movements in preterm infants.
Hitzert MM; Benders MJ; Roescher AM; van Bel F; de Vries LS; Bos AF
Pediatr Res; 2012 Jan; 71(1):100-6. PubMed ID: 22289857
[TBL] [Abstract][Full Text] [Related]
3. Functional outcome at school age of preterm-born children treated with high-dose dexamethasone.
Hitzert MM; Van Braeckel KN; de Bok M; Maathuis CG; Roze E; Bos AF
Early Hum Dev; 2014 May; 90(5):253-8. PubMed ID: 24602475
[TBL] [Abstract][Full Text] [Related]
4. Finding the optimal postnatal dexamethasone regimen for preterm infants at risk of bronchopulmonary dysplasia: a systematic review of placebo-controlled trials.
Onland W; Offringa M; De Jaegere AP; van Kaam AH
Pediatrics; 2009 Jan; 123(1):367-77. PubMed ID: 19117904
[TBL] [Abstract][Full Text] [Related]
5. Trajectories of general movements from birth to term-equivalent age in infants born <30 weeks' gestation.
Olsen JE; Brown NC; Eeles AL; Lee KJ; Anderson PJ; Cheong JL; Doyle LW; Spittle AJ
Early Hum Dev; 2015 Dec; 91(12):683-8. PubMed ID: 26513629
[TBL] [Abstract][Full Text] [Related]
6. Does a detailed assessment of poor repertoire general movements help to identify those infants who will develop normally?
Nakajima Y; Einspieler C; Marschik PB; Bos AF; Prechtl HF
Early Hum Dev; 2006 Jan; 82(1):53-9. PubMed ID: 16153788
[TBL] [Abstract][Full Text] [Related]
7. Randomized Trial of 42-Day Compared with 9-Day Courses of Dexamethasone for the Treatment of Evolving Bronchopulmonary Dysplasia in Extremely Preterm Infants.
Marr BL; Mettelman BB; Bode MM; Gross SJ
J Pediatr; 2019 Aug; 211():20-26.e1. PubMed ID: 31349916
[TBL] [Abstract][Full Text] [Related]
8. Randomized, double-blinded trial of low-dose dexamethasone: II. Functional residual capacity and pulmonary outcome in very low birth weight infants at risk for bronchopulmonary dysplasia.
McEvoy C; Bowling S; Williamson K; McGaw P; Durand M
Pediatr Pulmonol; 2004 Jul; 38(1):55-63. PubMed ID: 15170874
[TBL] [Abstract][Full Text] [Related]
9. General movements in early infancy predict neuromotor development at 9 to 12 years of age.
Groen SE; de Blécourt AC; Postema K; Hadders-Algra M
Dev Med Child Neurol; 2005 Nov; 47(11):731-8. PubMed ID: 16225735
[TBL] [Abstract][Full Text] [Related]
10. Qualitative assessment of general movements in high-risk preterm infants with chronic lung disease requiring dexamethasone therapy.
Bos AF; Martijn A; van Asperen RM; Hadders-Algra M; Okken A; Prechtl HF
J Pediatr; 1998 Feb; 132(2):300-6. PubMed ID: 9506645
[TBL] [Abstract][Full Text] [Related]
11. [Effect of corticosteroids on lung function and the clinical course of bronchopulmonary dysplasia in premature infants with a birth weight below 1,500 g].
Hanssler L; Zhou C; Roll C; Wiesemann HG
Klin Padiatr; 1994; 206(5):372-6. PubMed ID: 7799612
[TBL] [Abstract][Full Text] [Related]
12. Neonatal hydrocortisone treatment: neurodevelopmental outcome and MRI at school age in preterm-born children.
Rademaker KJ; Uiterwaal CS; Groenendaal F; Venema MM; van Bel F; Beek FJ; van Haastert IC; Grobbee DE; de Vries LS
J Pediatr; 2007 Apr; 150(4):351-7. PubMed ID: 17382109
[TBL] [Abstract][Full Text] [Related]
13. General movements in infants with autism spectrum disorders.
Phagava H; Muratori F; Einspieler C; Maestro S; Apicella F; Guzzetta A; Prechtl HF; Cioni G
Georgian Med News; 2008 Mar; (156):100-5. PubMed ID: 18403821
[TBL] [Abstract][Full Text] [Related]
14. A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia.
Cummings JJ; D'Eugenio DB; Gross SJ
N Engl J Med; 1989 Jun; 320(23):1505-10. PubMed ID: 2657423
[TBL] [Abstract][Full Text] [Related]
15. Early hypoadrenalism in premature infants at risk for bronchopulmonary dysplasia or death.
Nykänen P; Anttila E; Heinonen K; Hallman M; Voutilainen R
Acta Paediatr; 2007 Nov; 96(11):1600-5. PubMed ID: 17888053
[TBL] [Abstract][Full Text] [Related]
16. The quality of general movements in the first ten days of life in preterm infants.
de Vries NK; Bos AF
Early Hum Dev; 2010 Apr; 86(4):225-9. PubMed ID: 20488635
[TBL] [Abstract][Full Text] [Related]
17. [The use of postnatal corticosteroid therapy in premature infants to prevent or treat bronchopulmonary dysplasia: current situation and recommendations].
Jarreau PH; Fayon M; Baud O; Autret-Leca E; Danan M; de Verdelhan A; Castot A
Arch Pediatr; 2010 Oct; 17(10):1480-7. PubMed ID: 20864322
[TBL] [Abstract][Full Text] [Related]
18. The quality of preterm infants' spontaneous movements: an early indicator of intelligence and behaviour at school age.
Butcher PR; van Braeckel K; Bouma A; Einspieler C; Stremmelaar EF; Bos AF
J Child Psychol Psychiatry; 2009 Aug; 50(8):920-30. PubMed ID: 19457048
[TBL] [Abstract][Full Text] [Related]
19. Growth and neurodevelopmental outcomes after early low-dose hydrocortisone treatment in extremely low birth weight infants.
Watterberg KL; Shaffer ML; Mishefske MJ; Leach CL; Mammel MC; Couser RJ; Abbasi S; Cole CH; Aucott SW; Thilo EH; Rozycki HJ; Lacy CB
Pediatrics; 2007 Jul; 120(1):40-8. PubMed ID: 17606560
[TBL] [Abstract][Full Text] [Related]
20. Typical general movements at 2 to 4 months: Movement complexity, fidgety movements, and their associations with risk factors and SINDA scores.
Wu YC; Straathof EJM; Heineman KR; Hadders-Algra M
Early Hum Dev; 2020 Oct; 149():105135. PubMed ID: 32795785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
